Qvr LLC Pfizer Inc Call Options Transaction History

Qvr LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $3.22 Million - $4.2 Million	-77,100 Reduced 90.18%	8,400 $430,000
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $1.36 Million - $1.66 Million	31,100 Added 57.17%	85,500 $3.74 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $5.14 Million - $6.09 Million	-110,400 Reduced 66.99%	54,400 $2.85 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $7.51 Million - $9.31 Million	164,200 Added 27366.67%	164,800 $8.53 Million
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $3.04 Million - $4.5 Million	-73,500 Reduced 99.19%	600 $35,000

Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $1.86 Million - $2.39 Million	47,400 Added 177.53%	74,100 $3.19 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $743,336 - $842,076	20,700 Added 345.0%	26,700 $1.05 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $63,631 - $71,763	-1,900 Reduced 24.05%	6,000 $217,000
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $264,413 - $336,224	7,900 New	7,900 $291,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.